Arvind Nallakkan's guest appearances

Arvind Nallakkan

Digital Biotech

Michael Johnson

Leslie Loveless

Andy Scharenberg

OwlTail

Arvind joined Five Prime Therapeutics in 2009 and currently serves as Senior Vice President, Strategic Technology Operations.  He is responsible for Systems Engineering (Robotic Automation &amp; Automated Data Integration), Information Technology, Process Development, Manufacturing, and Supply Chain functions. Technology innovations at Five Prime include our robotics platform to produce, starting from our cDNA library, almost all of the proteins in the human extracellular proteome (about 6000 proteins) and robotic processes to agnostically screen the proteins in different disease models to discover novel biological functions leading to the first-in-class therapeutics.Five Prime has also built an innovative data integration platform that, using a unique database architecture, can automate data integration across all R&amp;D functions from clone to clinic (from early-stage discovery, through process development, manufacturing, and clinical trials). Arvind holds an M.B.A. from the University of California, Berkeley, and a Ph.D. in Chemical Engineering and Nanotechnology from the University of Washington, Seattle.

Arvind joined Five Prime Therapeutics in 2009 and currently serves as Senior Vice President, Strategic Technology Operations.  He is responsible for Systems Engineering (Robotic Automation &amp; Automated Data Integration), Information Technology, Process Development, Manufacturing, and Supply Chain functions. Technology innovations at Five Prime include our robotics platform to produce, starting from our cDNA library, almost all of the proteins in the human extracellular proteome (about 6000 proteins) and robotic processes to agnostically screen the proteins in different disease models to discover novel biological functions leading to the first-in-class therapeutics.Five Prime has also built an innovative data integration platform that, using a unique database architecture, can automate data integration across all R&amp;D functions from clone to clinic (from early-stage discovery, through process development, manufacturing, and clinical trials).<br> <br>Arvind holds an M.B.A. from the University of California, Berkeley, and a Ph.D. in Chemical Engineering and Nanotechnology from the University of Washington, Seattle.